Minute-Scale Construction of Fluorinated Nitrogen-Bridged Bicycles: Pd(II)/Pd(IV) Cascade Chemistry and a Pd(IV) “Dyotropic (Paired-Migration)” Rearrangement Driving Strain-Release Ring Expansion

Why does a “fluorinated nitrogen-bridged bicycle” attract attention?

Nitrogen-bridged frameworks (rigid bicyclic amines) are widely used in medicinal chemistry to increase three-dimensionality and conformational restriction, thereby influencing target binding, basicity, and metabolic stability. 2-Azabicyclo[3.2.1]octane is a representative example: it has a distinctive structure and strong application potential, yet is “not easy to synthesize” due to skeletal strain and the multi-step construction typically required.

Going a step further, if fluorine can be installed precisely onto such bridged scaffolds in the same step, it becomes possible to access a diverse scaffold library for structure–activity relationship (SAR) exploration via a shorter synthetic route.

Research Highlight: A Key Breakthrough from Prof. Jiepeng Zhu’s Group (EPFL) in JACS 2025

Key Point	Relevant Information
Team / Journal	EPFL (École Polytechnique Fédérale de Lausanne), Prof. Jiepeng Zhu group; JACS 2025; DOI: 10.1021/jacs.5c01108
What the reaction does	Converts N-protected 2-(2-amidoethyl)-1-methylenecyclobutanes (amide-type N protection including sulfonamides / amides / carbamates, etc.) into 1-fluoro-2-azabicyclo[3.2.1]octanes
How “fast” it is	Pd(hfacac)₂ (5 mol%) + Selectfluor (2.0 equiv), MeCN, 60 °C, 10 min
How many bonds are built in one step	In the domino/cascade sequence, C–N, C–C, and C–F bonds are formed
A traditional pain point addressed	In Pd(II)/Pd(IV) oxidative cyclizations, “protecting-group-controlled divergent cyclization” is common; here, the outcome becomes: the cyclization mode is no longer dictated by the N-protecting group
What else can be expanded	The bridgehead position of the product can undergo further functionalization via an “apparent anti-Bredt bridgehead iminium” intermediate pathway

Research Question: Why are “protecting groups” so troublesome in classical Pd(II)/Pd(IV) oxidative cyclizations?

In classic Pd(II)/Pd(IV) oxidative cyclizations, cyclization products derived from pent-4-en-1-amine substrates (e.g., pyrrolidine vs piperidine) often show “reaction divergence” depending on the N-protecting group. This means that even with similar substrate backbones, changing only the protecting group can lead to completely different cyclization outcomes—adding substantial trial-and-error cost for method generality and substrate compatibility.

Where is the “novelty” of this work?

Highlight 1: Turning “protecting-group-controlled divergence” into “protecting-group-independent selectivity”

1. The abstract explicitly states: under these conditions, “the cyclization mode remains independent of the N-protecting group.”
2. Scheme 3b shows that different protecting groups (nosyl, benzoyl, acetyl, Cbz) still deliver the same class of bridged products under identical conditions (yields differ, but the pathway is consistent), effectively taking “divergence control” away from the protecting group.

Note: “Cyclization mode independent of protecting group” does not mean “no protecting group is needed”—the substrates are still N-protected.

Highlight 2: “Skeletal editing” via a Pd(IV) dyotropic rearrangement (strain-release driven)

1. This reaction converts the small-ring strain of methylenecyclobutane into the “driving force” for skeletal rearrangement and ring expansion, and undergoes a chemoselective dyotropic rearrangement at the Pd(IV) stage to ultimately deliver the bridged product.
2. 5-exo-trig amidopalladation → Pd(II) oxidation → dyotropic rearrangement → C–F reductive elimination

Background: Pd(IV) dyotropic rearrangement is not a concept introduced out of nowhere. A 2021 Nature Chemistry report showed that a “1,2-position interchange” (dyotropic rearrangement) between adjacent C–C and C–Pd(IV) bonds can occur under mild conditions and can be leveraged in reaction design for key C–F reductive elimination steps. This provided a methodological context for treating such rearrangements as reaction-design building blocks.

Highlight 3: Not only “cyclization,” but also a bridgehead “secondary functionalization entry point”

The abstract notes that the bridgehead position can be diversified via an “apparent anti-Bredt bridgehead iminium” intermediate.

1. Bridgehead allylation: BF₃·Et₂O + allyltrimethylsilane to introduce an allyl group
2. Bridgehead alkynyl/arylalkynylation: BF₃·Et₂O + potassium trifluoro(phenylethynyl)borate to introduce an alkynyl fragment

For medicinal chemistry, this combination—“rapid scaffold construction first, then derivatization at a key position”—is particularly well suited for SAR expansion.

How to understand the mechanism? A “relay race” explanation

Leg 1: 5-exo-trig amidopalladation (bringing Pd(II) to the right carbon framework)

• Pd(II) first coordinates to the alkene. Then the N-protected amide-type N undergoes 5-exo-trig amidopalladation, forming an alkyl–Pd(II) intermediate and completing the first key bond formation (C–N).

Leg 2: Oxidation to Pd(IV) must “happen first”

• Synfacts notes that without Selectfluor, retro-carbopalladation and subsequent β-H elimination are observed. This indicates that to enter the dyotropic rearrangement channel, the key is to oxidize Pd(II) to Pd(IV) as quickly as possible.

Leg 3: Pd(IV)-dyotropic rearrangement (strain-release-driven skeletal rearrangement / ring expansion)

• A chemoselective dyotropic rearrangement occurs at the Pd(IV) stage (which can be viewed as a 1,2-position interchange / paired migration between C–C and C–Pd(IV) bonds). Cyclobutane strain provides the driving force, enabling connectivity rearrangement and guiding formation of the bridged scaffold.

Leg 4: C–F reductive elimination (installing fluorine into the final framework)

• A Pd(IV) C–F bond-forming reductive elimination then releases the product, while the catalyst returns to Pd(II) and enters the next Pd(II)/Pd(IV) turnover.

Leg 5: Apparent anti-Bredt bridgehead iminium pathway (entry point for late-stage functionalization)

• This step is not part of the “domino main catalytic sequence.” Rather, under specific activation conditions, the product can proceed via an apparent anti-Bredt bridgehead iminium intermediate to enable further bridgehead functionalization—an extension emphasized by the authors.

Experimental Chemicals List and Selection Guide

Category	CAS No.	Aladdin Catalog No.	Chemical Name	Specification / Purity	Use / Selection Notes
A. Core reaction triad (essential)	64916-48-9	P124121	Palladium(II) hexafluoroacetylacetonate, Pd(hfacac)₂	≥98%	Main catalyst. Catalyst purity and water/halide/metal impurities can affect reproducibility; store sealed and dry.
	140681-55-6	S101457	Selectfluor (N-fluoro-N′-(chloromethyl)… bis(tetrafluoroborate))	≥95%	Oxidant / electrophilic F source; drives Pd(II)→Pd(IV) and enables C–F formation; hygroscopic—weigh quickly in a dry environment and store sealed.
	75-05-8	A294970	Acetonitrile (ACN)	PrimorTrace™, electronic grade, ≥99.999% metals basis	Reaction solvent. For trace-metal-sensitive systems, prefer low-metal solvent to reduce background variables (use COA metrics as reference).
B. Reaction media & solvents (required / common)	109-99-9	T103262	Tetrahydrofuran (THF)	Anhydrous, ≥99.9%, inhibitor-free	Often used for follow-up transformations (e.g., SmI₂ systems) or certain derivatizations. Note peroxide risk and storage lifetime.
	75-09-2	D433565	Dichloromethane (DCM)	Anhydrous, ≥99.8%, contains 40–150 ppm amylene as stabilizer	Used for Lewis-acid/bridgehead functionalization or extraction.
	7732-18-5	W433885	Water	MS grade (MS), UltraPureChrom™, UHPLC grade	For quenching/addition steps or specific formulations. MS/UHPLC grade reduces background ions/organic impurities.
C. Oxidants / halogen sources & controls (controls / alternatives)	133745-75-2	F122293	N-Fluorobenzenesulfonimide (NFSI)	≥97%	Control electrophilic fluorine source / oxidizing system; useful for comparing “why Selectfluor.”
	128-09-6	N431696	N-Chlorosuccinimide (NCS)	Reagent grade	Control halogen source / oxidant; for comparing different halogenation/oxidation pathways or background reactions.
	3240-34-4	D106797	(Diacetoxyiodo)benzene (PIDA, PhI(OAc)₂)	≥98%	Control hypervalent iodine oxidant; corresponds to common Pd(II)/Pd(IV) oxidative cyclization systems.
D. Activators / Lewis acids / acids (key for bridgehead derivatization)	109-63-7	B104431	Boron trifluoride diethyl etherate (BF₃·Et₂O)	≥98%	Key Lewis acid to activate/capture bridgehead sites. Notes: strongly hygroscopic and corrosive; add at low temperature; dry inert atmosphere improves robustness.
	7550-45-0	T118447	Titanium tetrachloride (TiCl₄)	PrimorTrace™, ≥99.99% metals basis	Strong Lewis acid for specific transformations. Notes: strongly exothermic with water and highly moisture-sensitive; emphasize safe handling and strictly anhydrous conditions.
	76-05-1	T103294	Trifluoroacetic acid (TFA)	HPLC grade, ≥99.5%	Often used for deprotection/acidic workup; HPLC grade is better for analytical/purification workflows.
E. “Nucleophile library” for bridgehead functionalization (library expansion)	762-72-1	A107288	Allyltrimethylsilane	≥98%	Representative trapping reagent to introduce an allyl group at the bridgehead; suitable for SAR expansion.
	61550-02-5	T161752	2-(Trimethylsilyloxy)furan	≥96%	Introduces oxygen-containing heterocyclic fragments / scaffold extension; used for structural diversification.
F. Reductive & single-electron systems (follow-up transformations / mechanistic relevance)	617-86-7	T106570	Triethylsilane (NSC 93579)	≥98%	Reductant / hydride-source module; can be mentioned as a toolkit reagent for derivatization/workup.
	32248-43-4	S128315	Samarium(II) iodide (SmI₂)	0.1 M in THF, contains samarium as stabilizer	Single-electron reduction system. Exclude oxygen; control additions of water/amines, etc., as required by the system.
	123-75-1	P108562	Pyrrolidine	≥99%	Common additive/base/ligating component (relevant to SmI₂ or derivatization steps). Hygroscopic; store sealed.
G. Purification & drying materials (recommended essentials)	1344-28-1	A102003	Alumina (Al₂O₃)	PureSpectra™, spectroscopic grade, ≥99.999% metals basis	For adsorption/purification (removing acids/color/impurities, etc.); high purity helps reduce background contamination.
	112926-00-8	S743367	Color-indicating silica gel desiccant	Reagent grade	For moisture control and drying management to improve reproducibility; a practical example of “moisture-control strategy.”
	1643-19-2	T103374	Tetrabutylammonium bromide (TBAB)	Ion-pair chromatography grade, ≥99%	Additive / phase-transfer / ion-pair module; higher purity is preferred for analysis and mechanistic studies.

Scope and Limitations: What has this paper actually validated?

1. The substrate framework is specifically designed (strained small ring + amidoethyl side chain):

• The validated core system is N-protected 2-(2-amidoethyl)-1-methylenecyclobutane-type substrates. The success relies on the “strain release + Pd(IV) rearrangement” design logic; thus, it is closely tied to these structural features and should not be directly extrapolated to general alkenes/non-strained backbones.

2. Clear dependence on the oxidant/fluorine source (“racing” to Pd(IV) is critical):

• Selectfluor simultaneously serves as oxidant + electrophilic fluorine source to drive the key Pd(IV) channel. Without it or with alternative oxidant/fluorination systems, the mechanism may divert to non-productive rollback/elimination pathways. Therefore, “milder, lower-equivalent, greener” replacement systems remain open methodological space.

3. Functional-group compatibility boundary inherent to strong oxidant / electrophilic fluorine sources (a common Selectfluor constraint):

• Because Selectfluor combines strong oxidizing ability with F⁺ transfer, easily oxidized or strongly electron-donating functionalities (e.g., some electron-rich arenes; certain sulfur/phosphorus/amine-sensitive motifs; oxidizable enol ethers/thioethers) require additional evaluation. Even if the main pathway proceeds, competitive oxidation, side reactions, or yield erosion can occur—this is a broadly relevant compatibility boundary for Selectfluor-based systems.

4. Bridgehead diversification requires strong activation (iminium channel):

• Bridgehead derivatization proceeds via an apparent anti-Bredt bridgehead iminium intermediate and often relies on Lewis acids such as BF₃·Et₂O for activation/capture. Acid-sensitive functionalities and complex substrates may therefore require case-by-case assessment and condition re-optimization.

5. “Protecting-group independence” should be bounded to the tested set:

• The claim that cyclization mode is independent of the N-protecting group should be interpreted as holding within the tested protecting-group set and substrate class. It does not automatically guarantee the same behavior for untested protecting groups (more strongly electron-withdrawing/strongly coordinating/migratory groups) or for substantially different substrate architectures.

6. “Not protecting-group-controlled” ≠ “no protecting group needed”:

• The method is currently established on N-protected substrates. The generality toward free amines, other amine families, or broader N-types requires further systematic validation.

Future Directions Worth Exploring

1. Milder, more controllable Pd(II)→Pd(IV) triggering

• Better decoupling/controlling “oxidation” vs “fluorination” (or introducing electrochemical/photochemical oxidation) to reduce reliance on Selectfluor’s strong oxidizing nature and to suppress side reactions.

2. A functional-group tolerance map and rule-based selection guidance

• Systematically defining which functionalities are stable vs prone to competitive oxidation in the Selectfluor/Pd(IV) window—moving from “testing more substrates” to “predictive tolerance guidelines” for late-stage diversification of complex molecules.

3. Further boundarying of “protecting-group-independent cyclization”

• Expanding the protecting-group set and N-types (more strongly electron-withdrawing/ligating PGs; systems closer to free amines) to test how far the conclusion can be extrapolated.

4. Broadening scaffold space: generalizing the “strain release + Pd(IV) dyotropic rearrangement” paradigm

• Exploring more strained small rings/substitution patterns/connectivities to assess whether additional 3D nitrogen scaffolds can be accessed beyond the current exemplar.

5. Milder, more modular bridgehead derivatization + process validation

• Developing a more general, milder toolbox for “bridgehead iminium capture,” while also addressing scale-up realities such as heat management, dosing strategy, and impurity profiling/control.

References

1. Yang, B.; Yang, G.; Wang, Q.; Zhu, J. Pd-Catalyzed Strain-Releasing Dyotropic Rearrangement: Ring-Expanding Amidofluorination of Methylenecyclobutanes. J. Am. Chem. Soc. 2025, 147(10), 8969–8977. DOI: 10.1021/jacs.5c01108.

2. Lautens, M.; Johnson, C. E. Synthesis of Bicyclic Piperidines Enabled by a Palladium(IV) Dyotropic Rearrangement. Synfacts 2025, 21(05), 473. DOI: 10.1055/a-2558-0268.

3. Cao, J.; Wu, H.; Wang, Q.; Zhu, J. C–C Bond Activation Enabled by Dyotropic Rearrangement of Pd(IV) Species. Nat. Chem. 2021, 13(7), 671–676. DOI: 10.1038/s41557-021-00698-y.

4. Fernández, I.; Cossío, F. P.; Sierra, M. A. Dyotropic Reactions: Mechanisms and Synthetic Applications. Chem. Rev. 2009, 109(12), 6687–6711. DOI: 10.1021/cr900209c.

5. Champagne, P. A.; Desroches, J.; Hamel, J.-D.; Vandamme, M.; Paquin, J.-F. Monofluorination of Organic Compounds: 10 Years of Innovation. Chem. Rev. 2015, 115(17), 9073–9174. DOI: 10.1021/cr500706a.

6. Lovering, F.; Bikker, J.; Humblet, C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J. Med. Chem. 2009, 52(21), 6752–6756. DOI: 10.1021/jm901241e.

7. Minatti, A.; Muñiz, K. Intramolecular Aminopalladation of Alkenes as a Key Step to Pyrrolidines and Related Heterocycles. Chem. Soc. Rev. 2007, 36(7), 1142–1152. DOI: 10.1039/B607474J.

8. Kočovský, P.; Bäckvall, J.-E. The syn/anti-Dichotomy in the Palladium-Catalyzed Addition of Nucleophiles to Alkenes. Chem.—Eur. J. 2015, 21(1), 36–56. DOI: 10.1002/chem.201404070.

Aladdin: https://www.aladdinsci.com/